Panel Discussion | Consensus on Retrograde Approach

Sunday, March 9, 2025

9:49 AM - 10:05 AM ET

Panel Moderator(s)

Lorenzo Azzalini, MD, PhD, MSc

Interventional Cardiologist
University of Washington
Seattle, Washington, United States

No relationships to disclose
Kevin Croce, MD, PhD

Director of CTO and Complex PCI Programs
Brigham and Women's Hospital
Harvard Medical School
Boston, Massachusetts, United States

Disclosure information not submitted.
Carlo Di Mario, MD

Professor
University of Florence
Florence, Toscana, Italy

No relationships to disclose

Panel Discussant(s)

Khaldoon Alaswad, MD, FACC, FSCAI

Director, Catheterization Laboratory
Henry Ford Hospital and Health System
Detroit, Michigan, United States

No relationships to disclose
Salman Arain, MD, FACC, FSCAI

Associate Professor of Medicine - Cardiology
University of Texas Health Sciences Center - Houston
Houston, Texas, United States

Disclosure(s): Boston Scientific: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Teleflex Inc: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Joaquim Barboza, MD

Program Director - Interventional Cardiology Fellowship
University of Illinois Chicago

No relationships to disclose
Dimitri Karmpaliotis, MD, PhD, FACC, FSCAI

Founder
Cardiac Intervention Consulting
New York, New York, United States

Disclosure(s): No financial relationships to disclose
Craig Thompson, MD, MMSc

Director, Interventional Cardiology Hartford Healthcare Heart and Vascular Institute
Hartford Healthcare
Hartford, Connecticut, United States

Disclosure information not submitted.
Gerald S. Werner, MD, PhD, FSCAI

Director
Klinikum Darmstadt GmbH
Darmstadt, Hessen, Germany

No relationships to disclose
Masahisa Yamane, MD

Senior Advisor
Saitama Sekishinkai Hospital
Tokyo, Tokyo, Japan

No relationships to disclose

Disclosure(s):

Lorenzo Azzalini, MD, PhD, MSc: Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing); Abiomed: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); GE Healthcare: Consulting Fees (e.g., advisory boards) (Terminated, December 11, 2024); HeartFlow: Consulting Fees (e.g., advisory boards) (Ongoing); Reflow Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Shockwave Medical, Inc: Consulting Fees (e.g., advisory boards) (Ongoing); Teleflex: Consulting Fees (e.g., advisory boards) (Ongoing)

Carlo Di Mario, MD: BSC, Amgen, BCRI, PERC, NAMSA, BMS, Janssen, Regeneron: Grant/Research Support (Terminated, September 7, 2023)

Khaldoon Alaswad, MD, FACC, FSCAI: No financial relationships to disclose

Salman Arain, MD, FACC, FSCAI: Boston Scientific: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Teleflex Inc: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Joaquim Barboza, MD: Abiomed Inc: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scietific: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Dimitri Karmpaliotis, MD, PhD, FSCAI: No financial relationships to disclose

Craig Thompson, MD, MMSc: kardion: Consultant (Ongoing); Medtronic: Consultant (Ongoing); Teleflex: Consultant (Ongoing); Terumo Corporation: Consultant (Ongoing)

Gerald S. Werner, MD, PhD, FSCAI: Terumo Corporation: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated)

Masahisa Yamane, MD: Asahi Intecc, Japan: Consulting Fees (e.g., advisory boards) (Ongoing)